课题基金 / 基金详情

Human Amnion Cells as a therapy for Preterm Lung Disease

Human Amnion Cells as a therapy for Preterm Lung Disease
人羊膜细胞治疗早产肺病
批准号:
nhmrc : 579742
负责人:
Dr Ryan Hodges
金额:
$6.98万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Postgraduate Scholarships
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-01 至 2011-12-31

项目摘要

项目成果

Dr Ryan Hodges的其他基金

相似基金

相关文献

中文摘要
翻译
由于肺部发育不成熟,早产儿通常会有严重的呼吸困难,这些困难可能会持续一生。羊膜细胞来自子宫内包裹婴儿和胎盘的膜,其行为类似干细胞,可以发育成肺细胞。通过动物模型,我们将把这些细胞注入受损的早产儿肺部,看看它们是否能修复肺组织。我们希望这将提高早产儿的存活率,并有助于预防长期肺部疾病。
英文摘要
Premature babies often have serious breathing difficulties due to immature lungs, and these can remain life long. Amnion cells, which are from the membrane that surrounds the baby and placenta in the womb, behave like stem cells and can develop into lung cells. Using an animal model, we will give these cells to damaged premature lungs, and see if they can repair the lung tissue. We are hopeful this will improve the survival of premature babies and help prevent long term lung disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiac function in the growth restricted fetus: the effects of betamethasone and melatonin
  • 批准号:
    nhmrc : 1036142
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $26.86万
  • 财政年份:
    2012
  • 负责人:
    Dr Ryan Hodges
  • 依托单位:
海外基金